Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Asoprisnil in Uterine Leiomyomata
NCT00156156Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asoprisnil in Uterine Fibroids (UF), sponsored by Abbott Laboratories. Started Nov 2004; status: completed.
02
Drugs
asoprisnil
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00156156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156156.